HomeAVBP • NASDAQ
add
Arrivent Biopharma Inc
Previous close
$26.86
Day range
$23.97 - $27.11
Year range
$14.35 - $36.20
Market cap
838.39M USD
Avg Volume
154.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.23M | 44.96% |
Net income | -20.56M | -42.80% |
Net profit margin | — | — |
Earnings per share | -0.61 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 282.86M | 70.03% |
Total assets | 292.71M | 60.84% |
Total liabilities | 15.22M | 50.67% |
Total equity | 277.49M | — |
Shares outstanding | 33.70M | — |
Price to book | 3.26 | — |
Return on assets | -20.14% | — |
Return on capital | -21.09% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -20.56M | -42.80% |
Cash from operations | -16.34M | -5.85% |
Cash from investing | — | — |
Cash from financing | 531.00K | 151.40% |
Net change in cash | -15.81M | 4.01% |
Free cash flow | -10.92M | -2.26% |
About
Founded
2021
Headquarters
Website
Employees
40
